The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weighardt, H.
Right arrow Articles by Holzmann, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weighardt, H.
Right arrow Articles by Holzmann, B.
The Journal of Immunology, 2006, 177: 5623-5630.
Copyright © 2006 by The American Association of Immunologists, Inc.

Type I IFN Modulates Host Defense and Late Hyperinflammation in Septic Peritonitis1

Heike Weighardt2,*, Simone Kaiser-Moore*, Sylvia Schlautkötter*, Tanja Rossmann-Bloeck*, Ulrike Schleicher{dagger}, Christian Bogdan{dagger} and Bernhard Holzmann*

* Department of Surgery, Technische Universität München, Munich, Germany; and {dagger} Department of Microbiology and Hygiene, Institute of Medical Microbiology and Hygiene, University Clinic of Freiburg, Freiburg, Germany

TLRs are considered important for the control of immune responses during endotoxic shock or polymicrobial sepsis. Signaling by TLRs may proceed through the adapter proteins MyD88 or TIR domain-containing adaptor inducinng IFN-beta. Both pathways can lead to the production of type I IFNs (IFN-{alpha}beta). In the present study, the role of the type I IFN pathway for host defense and immune pathology in sepsis was investigated using a model of mixed bacterial peritonitis. Systemic levels of IFN-{alpha}beta protein were markedly elevated during septic peritonitis. More detailed analyses revealed production of IFN-beta, but not IFN-{alpha} subtypes, and identified CD11b+CD11c macrophage-like cells as major producers of IFN-beta. The results further demonstrate that in IFN-{alpha}beta receptor I chain (IFNARI)-deficient mice, the early recruitment of neutrophils to the infected peritoneal cavity was augmented, most likely due to an increased local production of MCP-1 and leukotriene B4. In the absence of IFNARI, peritoneal neutrophils also exhibited enhanced production of reactive oxygen intermediates and elevated expression of Mac-1. Conversely, administration of recombinant IFN-beta resulted in reduced leukotriene B4 levels and decreased peritoneal neutrophil recruitment and activation. Analysis of the cytokine response to septic peritonitis revealed that IFNARI deficiency strongly attenuated late, but not early, hyperinflammation. In accordance with these findings, bacterial clearance and overall survival of IFNARI–/– mice were improved. Therefore, the present study reveals critical functions of the type I IFN pathway during severe mixed bacterial infections leading to sepsis. The results suggest that type I IFN exerts predominantly adverse effects under these conditions.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Deutsche Forschungsgemeinschaft Grants (SFB 576 Project A7 to B.H. and H.W.) and SFB 620 Project A9; DFG Bo996/3-2 and 3-3 (to U.S. and C.B.) and by the Kommission für Klinische Forschung, Klinikum rechts der Isar.

2 Address correspondence and reprint requests to Dr. Heike Weighardt, Department of Surgery, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany. E-mail address: weighardt{at}chir.med.tu-muenchen.de

3 Abbreviations used in this paper: TRIF, TIR domain-containing adaptor inducing IFN-beta; CASP, colon ascendens stent peritonitis; IFNAR, IFN-{alpha}beta receptor; IP10, IFN-{gamma}-inducible protein 10; VSV, vesicular stomatitis virus; LTB4, leukotriene B4.




This article has been cited by other articles:


Home page
J. Immunol.Home page
T. Secher, V. Vasseur, D. M. Poisson, J. A. Mitchell, F. Q. Cunha, J. C. Alves-Filho, and B. Ryffel
Crucial Role of TNF Receptors 1 and 2 in the Control of Polymicrobial Sepsis
J. Immunol., June 15, 2009; 182(12): 7855 - 7864.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-H. Kim, S.-J. Kim, I.-S. Lee, M.-S. Lee, S. Uematsu, S. Akira, and K. I. Oh
Bacterial Endotoxin Induces the Release of High Mobility Group Box 1 via the IFN-{beta} Signaling Pathway
J. Immunol., February 15, 2009; 182(4): 2458 - 2466.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Wynn, P. O. Scumpia, R. D. Winfield, M. J. Delano, K. Kelly-Scumpia, T. Barker, R. Ungaro, O. Levy, and L. L. Moldawer
Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists
Blood, September 1, 2008; 112(5): 1750 - 1758.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Qiu, Y. Fan, A. G. Joyee, S. Wang, X. Han, H. Bai, L. Jiao, N. Van Rooijen, and X. Yang
Type I IFNs Enhance Susceptibility to Chlamydia muridarum Lung Infection by Enhancing Apoptosis of Local Macrophages
J. Immunol., August 1, 2008; 181(3): 2092 - 2102.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Biondo, A. Midiri, M. Gambuzza, E. Gerace, M. Falduto, R. Galbo, A. Bellantoni, C. Beninati, G. Teti, T. Leanderson, et al.
IFN-{alpha}/{beta} Signaling Is Required for Polarization of Cytokine Responses toward a Protective Type 1 Pattern during Experimental Cryptococcosis
J. Immunol., July 1, 2008; 181(1): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Biswas, P. Bist, M. K. Dhillon, T. Kajiji, C. del Fresno, M. Yamamoto, E. Lopez-Collazo, S. Akira, and V. Tergaonkar
Role for MyD88-Independent, TRIF Pathway in Lipid A/TLR4-Induced Endotoxin Tolerance
J. Immunol., September 15, 2007; 179(6): 4083 - 4092.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Magnusson, R. Tobes, J. Sancho, and E. Pareja
Cutting Edge: Natural DNA Repetitive Extragenic Sequences from Gram-Negative Pathogens Strongly Stimulate TLR9
J. Immunol., July 1, 2007; 179(1): 31 - 35.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. F. Weber, S. Schlautkotter, S. Kaiser-Moore, F. Altmayr, B. Holzmann, and H. Weighardt
Inhibition of Interleukin-22 Attenuates Bacterial Load and Organ Failure during Acute Polymicrobial Sepsis
Infect. Immun., April 1, 2007; 75(4): 1690 - 1697.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.